Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

March 2013 - FRMC

Refractory Gastroesophageal Reflux Disease: A Review
03/18/2013

Tori Socha

Tori Socha
Gastroesophageal reflux disease (GERD) develops when reflux of the contents of the stomach cause troublesome symptoms or complications. There is a high prevalence of GERD among the world population, including an estimated 12% to 20% of the...
Gastroesophageal reflux disease (GERD) develops when reflux of the contents of the stomach cause troublesome symptoms or complications. There is a high prevalence of GERD among the world population, including an estimated 12% to 20% of the...
Gastroesophageal reflux disease...
03/18/2013
First Report Managed Care
Utilizing the GERD Impact Scale to Evaluate Treatment Effectiveness
03/18/2013

Tori Socha

Tori Socha
Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal disorders in the United States.
Gastroesophageal reflux disease (GERD) is one of the most common gastrointestinal disorders in the United States.
Gastroesophageal reflux disease...
03/18/2013
First Report Managed Care
Weight Reduction in Obese Patients with Zonisamide
03/18/2013

Tori Socha

Tori Socha
Obese patients who have not achieved adequate weight loss through changes in lifestyle have few nonsurgical therapeutic options. In a recent 16-week trial, the antiepileptic drug zonisamide demonstrated weight loss efficacy in obese adults...
Obese patients who have not achieved adequate weight loss through changes in lifestyle have few nonsurgical therapeutic options. In a recent 16-week trial, the antiepileptic drug zonisamide demonstrated weight loss efficacy in obese adults...
Obese patients who have not...
03/18/2013
First Report Managed Care
Early Resection versus Watchful Waiting in Low-Grade Gliomas
03/18/2013

Tori Socha

Tori Socha
The World Health Organization has identified grade II astrocytomas, oligodendrogliomas, and oligoastrocytomas as diffuse low-grade gliomas (LGGs). Surgery is not usually considered for treatment of LGGs and, because current evidence of the...
The World Health Organization has identified grade II astrocytomas, oligodendrogliomas, and oligoastrocytomas as diffuse low-grade gliomas (LGGs). Surgery is not usually considered for treatment of LGGs and, because current evidence of the...
The World Health Organization...
03/18/2013
First Report Managed Care
Dexamethasone Shows No Cardiovascular Advantage
03/18/2013

Eileen Koutnik-FotopoulosÔªø

Eileen Koutnik-FotopoulosÔªø
The use of high-dose dexamethasone as a prophylactic for patients undergoing cardiac surgery did not lower the 30-day incidence of major cardiovascular events compared with placebo, however, it may reduce occurrence of respiratory failure and...
The use of high-dose dexamethasone as a prophylactic for patients undergoing cardiac surgery did not lower the 30-day incidence of major cardiovascular events compared with placebo, however, it may reduce occurrence of respiratory failure and...
The use of high-dose...
03/18/2013
First Report Managed Care
Insurance Status and Postoperative Mortality
03/18/2013

Tori Socha

Tori Socha
Hypothesizing that insurance status may be associated with differences in specialized medical and surgical care, researchers noted that nonprivately insured patients fare worse postoperatively than privately insured patients. Those...
Hypothesizing that insurance status may be associated with differences in specialized medical and surgical care, researchers noted that nonprivately insured patients fare worse postoperatively than privately insured patients. Those...
Hypothesizing that insurance...
03/18/2013
First Report Managed Care

News

News
Literature Review Assesses Economic Burden of MS
03/18/2013

Kerri Fitzgerald

Kerri Fitzgerald
Multiple sclerosis (MS) is a costly chronic disease that tends to have an early onset, with most patients diagnosed between 20 and 40 years of age. Due to its onset during a patient’s most productive working years, social costs associated...
Multiple sclerosis (MS) is a costly chronic disease that tends to have an early onset, with most patients diagnosed between 20 and 40 years of age. Due to its onset during a patient’s most productive working years, social costs associated...
Multiple sclerosis (MS) is a...
03/18/2013
First Report Managed Care
News
No Significant Clinical Benefit in Combination Therapy for MS
03/18/2013

Kerri Fitzgerald

Kerri Fitzgerald
Disease-modifying therapies (DMTs) have been available for the treatment of relapsing-remitting multiple sclerosis (MS) since 1993. Currently, 9 distinct marketed entities, representing 6 different therapeutic strategies, all...
Disease-modifying therapies (DMTs) have been available for the treatment of relapsing-remitting multiple sclerosis (MS) since 1993. Currently, 9 distinct marketed entities, representing 6 different therapeutic strategies, all...
Disease-modifying therapies...
03/18/2013
First Report Managed Care
News
Natalizumab for Pediatric Patients with MS
03/18/2013

Tori Socha

Tori Socha
Two to 5% of patients with multiple sclerosis (MS) experience their first symptoms before they are 18 years of age. Compared with adults with MS, patients £18 years of age commonly have higher relapse rates and often reach disability...
Two to 5% of patients with multiple sclerosis (MS) experience their first symptoms before they are 18 years of age. Compared with adults with MS, patients £18 years of age commonly have higher relapse rates and often reach disability...
Two to 5% of patients with...
03/18/2013
First Report Managed Care
News
Disability Expectancy Table Useful for Patients and Clinicians
03/18/2013

Tori Socha

Tori Socha
The Disability Expectancy Table (DET) was created in order to collect disability information on patients with multiple sclerosis (MS).
The Disability Expectancy Table (DET) was created in order to collect disability information on patients with multiple sclerosis (MS).
The Disability Expectancy Table...
03/18/2013
First Report Managed Care

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 2

Current Issue

June 2024
Volume 21
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

What's Trending?

News
Express Scripts Reports Prescription Drug Spending Slowed in 2016
02/06/2017
The pharmacy benefit manager, Express Scripts, reported that growth in prescription drug spending slowed to less than 4% between 2015 and 2016.
The pharmacy benefit manager, Express Scripts, reported that growth in prescription drug spending slowed to less than 4% between 2015 and 2016.
The pharmacy benefit manager,...
02/06/2017
First Report Managed Care
News
Substantial Economic Burden Associated With Lupus Nephritis 
12/17/2021
Jolynn Tumolo
“The consensus across the 22 studies was that the economic burden of lupus nephritis is substantial,” researchers wrote, “particularly in active or severe disease, or if there is progression to end-stage kidney disease.”
“The consensus across the 22 studies was that the economic burden of lupus nephritis is substantial,” researchers wrote, “particularly in active or severe disease, or if there is progression to end-stage kidney disease.”
“The consensus across the 22...
12/17/2021
First Report Managed Care
Study Identifies Cost of Having a Baby in the United States
04/22/2013

Tori Socha

Tori Socha
There are 3 goals in healthcare: (1) improved care, (2) improved outcomes, and (3) lower costs. Maternity care, which impacts approximately 85% of women during 1 or more episodes of care, provides opportunity for improvements in healthcare...
There are 3 goals in healthcare: (1) improved care, (2) improved outcomes, and (3) lower costs. Maternity care, which impacts approximately 85% of women during 1 or more episodes of care, provides opportunity for improvements in healthcare...
There are 3 goals in healthcare:...
04/22/2013
First Report Managed Care
News
J&J arthritis drug shows promise in mid-stage trial
06/07/2011
06/07/2011
First Report Managed Care
News
Wrinkle in Health Law Vexes Lawmakers’ Aides
07/30/2013
07/30/2013
First Report Managed Care

Video Insights

Hayward
Videos
Evolving Health Care Contact Centers Into Drivers of Value-Based Care
07/31/2024
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.
Discover how health care contact...
07/31/2024
First Report Managed Care
Lucille Accetta Headshot
Videos
Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024
06/11/2024
Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...
Key stakeholders in the health...
06/11/2024
First Report Managed Care
Melissa Andel, Principal, CommonHealth Solutions, LLC
Videos
Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers
05/24/2024
Melissa Andel, Principal, CommonHealth Solutions, LLC
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.
Learn about the impacts of the...
05/24/2024
First Report Managed Care
Joe DePinto Headshot
Videos
Navigating Payment Models in the CGT Landscape: Insights and Innovations
05/21/2024
Joe DePinto, Head of Cell, Gene, and Advanced Therapies, McKesson
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the evolution and challenges of payment models in the cell and gene therapy (CGT) space reviewed during his session at Asembia 2024.
An expert discusses the...
05/21/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Videos
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

March 2013 Volume 10 Issue 3

View Issue Archive
Editorial Correspondence

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement